This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/527886-india-moderna-covid-vaccine-emergency-use/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
India clears Moderna Covid-19 vaccine for restricted emergency use India clears Moderna Covid-19 vaccine for restricted emergency use
(about 2 months later)
The Drugs Controller General of India (DCGI) has given its approval to the Moderna Covid-19 vaccine, allowing Mumbai-based pharmaceutical company Cipla to begin importing the jab for restricted emergency use.The Drugs Controller General of India (DCGI) has given its approval to the Moderna Covid-19 vaccine, allowing Mumbai-based pharmaceutical company Cipla to begin importing the jab for restricted emergency use.
Confirming the emergency usage approval for the Moderna jab, Indian Health Ministry official VK Paul stated that “this new drug permission for restricted emergency use is now in operation.”Confirming the emergency usage approval for the Moderna jab, Indian Health Ministry official VK Paul stated that “this new drug permission for restricted emergency use is now in operation.”
Cipla, an Indian pharmaceutical company, requested approval to begin importing and marketing the Moderna Covid-19 vaccine on Monday, with the DCGI swiftly giving it the go ahead “as per the provisions of the new Drugs and Clinical Trial Rules.”Cipla, an Indian pharmaceutical company, requested approval to begin importing and marketing the Moderna Covid-19 vaccine on Monday, with the DCGI swiftly giving it the go ahead “as per the provisions of the new Drugs and Clinical Trial Rules.”
Separate to the statement on Moderna’s emergency usage approval, the DCGI confirmed that the US government has agreed to donate doses of the vaccine to the Indian government’s inoculation program under the Covax scheme. Separate to the statement on Moderna’s emergency usage approval, the DCGI confirmed that the US government has agreed to donate doses of the vaccine to the Indian government’s inoculation program under the Covax scheme. 
In May, it was reported that Cipla was close to reaching a deal with Moderna to bring 50 million doses of the Covid-19 vaccine to India by 2022. In May, it was reported that Cipla was close to reaching a deal with Moderna to bring 50 million doses of the Covid-19 vaccine to India by 2022. 
Moderna will join Covishield, Covaxin and Sputnik V as an approved Covid vaccine in India. The country’s health department is in the process of preparing to start using a domestically produced version of the Novavax jab. Pfizer is also reportedly “in the final stages” of securing approval for usage in India, according to company’s CEO Albert Bourla, with the pharma giant hoping to “finalize an agreement with the government” very soon.Moderna will join Covishield, Covaxin and Sputnik V as an approved Covid vaccine in India. The country’s health department is in the process of preparing to start using a domestically produced version of the Novavax jab. Pfizer is also reportedly “in the final stages” of securing approval for usage in India, according to company’s CEO Albert Bourla, with the pharma giant hoping to “finalize an agreement with the government” very soon.
India, which has recorded the second-highest tally of Covid cases in the world, has managed to vaccinate more than 329 million people to date.India, which has recorded the second-highest tally of Covid cases in the world, has managed to vaccinate more than 329 million people to date.
Since the start of the pandemic, the Asian nation has reported 396,730 deaths from the virus, and recently brought a deadly wave that plunged the nation into lockdown under control.Since the start of the pandemic, the Asian nation has reported 396,730 deaths from the virus, and recently brought a deadly wave that plunged the nation into lockdown under control.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.